Showing results (511-520 of 595) with videos related to

Sort By:
Pageof 60
Cytotherapy|March 14, 2024
Good Manufacturing Practice-compliant human induced pluripotent stem cells: from bench to putative clinical productsJuan J Novoa, Inge M Westra, Esther Steeneveld, et al.
JACC. Cardiovascular Interventions|January 8, 2016
Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents)Ajay J Kirtane, Puja B Parikh, Thomas D Stuckey, et al.
Journal of the American College of Cardiology|April 16, 2016
Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARISUsman Baber, Roxana Mehran, Gennaro Giustino, et al.
European Journal of Preventive Cardiology|March 11, 2026
Mortality score in chronic coronary syndrome: prediction model from the ISCHEMIA trialEliano P Navarese, Giuseppe Talanas, Dean J Kereiakes, et al.
The Canadian Journal of Cardiology|February 25, 2018
Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS StudyJaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 15, 2019
Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention-Results from the PROMETHEUS registryRishi Chandiramani, Huazhen Chen, Shunsuke Aoi, et al.
Nature Medicine|October 21, 2025
Cardiotropic AAV gene therapy for heart failure: a phase 1 trialTimothy D Henry, Eugene S Chung, Monica Alvisi, et al.
Cell Transplantation|May 7, 2016
Autologous CD34<sup>+</sup> Cell Therapy for Refractory Angina: 2-Year Outcomes From the ACT34-CMI StudyTimothy D Henry, Gary L Schaer, Jay H Traverse, et al.
ESC Heart Failure|March 2, 2021
Reparative cell therapy for the heart: critical internal appraisal of the field in response to recent controversiesThomas J Povsic, Ricardo Sanz-Ruiz, Andreu M Climent, et al.
Journal of the American Heart Association|February 26, 2025
A Framework for Exception From Informed Consent in Trials Enrolling Patients With ST-Segment-Elevation Myocardial Infarction and Cardiogenic ShockGraham Nichol, Neal W Dickert, Jacob E Moeller, et al.
Pageof 60